Statin use vs. average non-HDL cholesterol levels in Marshall Islands
Marshall Islands: Statin use vs. average non-HDL cholesterol levels was 3.3 in 2018. ▼ Falling
Statin use vs. average non-HDL cholesterol levels in Marshall Islands, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
The most recent figure for statin use vs. average non-hdl cholesterol levels in Marshall Islands is 3.3, measured in 2018. That is the lowest value across all 39 years on record.
That represents a change of down 5.7% over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in Marshall Islands peaked at 3.8 in 1989 and was at its lowest, 3.3, in 2017.
That places Marshall Islands 95th out of 191 countries with data for 2018, putting it in the middle of the range.
The long-run direction has been consistently falling across the 39 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 3.71 | 3.7 | 3.8 | 10 |
| 1990s | 3.74 | 3.7 | 3.8 | 10 |
| 2000s | 3.59 | 3.5 | 3.7 | 10 |
| 2010s | 3.4 | 3.3 | 3.5 | 9 |
Countries ranked near Marshall Islands
- 95 Algeria 3.3 compare
- 95 Azerbaijan 3.3 compare
- 95 Bahrain 3.3 compare
- 95 Barbados 3.3 compare
- 95 Bolivia 3.3 compare
- 95 Bosnia and Herzegovina 3.3 compare
- 95 Cambodia 3.3 compare
- 95 China 3.3 compare
- 95 Cuba 3.3 compare
- 95 Egypt 3.3 compare
- 95 Ghana 3.3 compare
- 95 Kiribati 3.3 compare
- 95 Laos 3.3 compare
- 95 Netherlands 3.3 compare
- 95 Spain 3.3 compare
- 95 Sri Lanka 3.3 compare
- 95 Suriname 3.3 compare
- 95 Turkey 3.3 compare
- 95 Turkmenistan 3.3 compare
- 95 United Kingdom 3.3 compare
- 95 United States 3.3 compare
More reference data data for Marshall Islands
- Universal right to vote 2 (2025)
- Free country 2 (2025)
- Civil liberties rating 1 (2025)
- Men's universal right to vote 1 (2025)
- Elected parliament 1 (2025)
- Competitive elections 1 (2025)
- Chief executive of the government is elected 1 (2025)
- Democracy 7 (2025)
- Universal right to vote in practice 2 (2025)
- Foreign aid received from governments and private foundations 710.23 million constant 2024 US$ (2024)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in Marshall Islands?
- Statin use vs. average non-hdl cholesterol levels in Marshall Islands was 3.3 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in Marshall Islands?
- The highest recorded value was 3.8 in 1989.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in Marshall Islands?
- The lowest recorded value was 3.3 in 2017.
- How does Marshall Islands rank for statin use vs. average non-hdl cholesterol levels?
- Marshall Islands ranks 95th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in Marshall Islands?
- Over the last ten years it is down 5.7%. The long-run trend across the full record is falling.
- Where does this Marshall Islands data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.